Language selection

Search

Patent 2512775 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent: (11) CA 2512775
(54) English Title: SEAL VALVE, CONNECTION PORT, MIX-FEED TUBE, CONNECTION DEVICE FOR LIQUID INFUSION, CIRCUIT AND CONNECTION SYSTEM FOR LIQUID INFUSION CIRCUIT THAT ARE FOR MEDICAL DEVICE
(54) French Title: SOUPAPE D'ETANCHEITE, PORT DE CONNEXION, TUBE D'ALIMENTATION DE MELANGE, DISPOSITIF DE CONNEXION POUR CIRCUITS DE PERFUSION DE LIQUIDES, ET SYSTEME DE CONNEXION POUR CIRCUITS DE PERFUSION DE LIQUIDES DESTINES A UN DISPOSITIF MEDICAL
Status: Deemed expired
Bibliographic Data
(51) International Patent Classification (IPC):
  • A61M 39/04 (2006.01)
  • A61M 39/26 (2006.01)
(72) Inventors :
  • FUKAI, AKITOSHI (Japan)
  • OKUI, YOSHIHITO (Japan)
  • TAKEUCHI, TOSHIAKI (Japan)
(73) Owners :
  • FUKAI KOGYO KABUSHIKI KAISHA (Japan)
(71) Applicants :
  • FUKAI KOGYO KABUSHIKI KAISHA (Japan)
(74) Agent: MACRAE & CO.
(74) Associate agent:
(45) Issued: 2011-03-22
(86) PCT Filing Date: 2004-01-08
(87) Open to Public Inspection: 2004-07-29
Examination requested: 2007-09-10
Availability of licence: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): Yes
(86) PCT Filing Number: PCT/JP2004/000083
(87) International Publication Number: WO2004/062721
(85) National Entry: 2005-07-07

(30) Application Priority Data:
Application No. Country/Territory Date
2003-3570 Japan 2003-01-09
2003-5978 Japan 2003-01-14
2003-114451 Japan 2003-04-18
2003-284147 Japan 2003-07-31

Abstracts

English Abstract




In a seal valve (20), a valve hole (20b) can be opened by pressing and
deforming the seal valve (20) with the head of a male-type connection mouth,
such as a mouth portion (401) of an injector (400), without making the head of
the male-type connection mouth to penetrate through the seal valve (20). A
connection port, a mix-feed tube, a connection device for a liquid infusion
circuit, and a connection system for a liquid infusion circuit use the seal
valve with the feature described above, realizing a needle-less environment.


French Abstract

Dans une soupape d'étanchéité (20), un orifice de soupape (20b) peut être ouvert par pression et déformation de la soupape d'étanchéité (20) avec un bec de connexion de type mâle, telle une partie de bec (401) d'un injecteur (400), sans obliger la tête du bec de connexion de type mâle à pénétrer la soupape d'étanchéité (20). Un port de connexion, un tube d'alimentation de mélange, un dispositif de connexion pour circuits de perfusion de liquides, et un système de connexion pour circuits de perfusion de liquides utilisent la soupape d'étanchéité selon les caractéristiques susmentionnées, ce qui permet un environnement sans aiguille.

Claims

Note: Claims are shown in the official language in which they were submitted.





CLAIMS


1. A connection port for a syringe, comprising:

a sealing valve, which is provided with an approximately
semispherical portion being directed convexly outward, made of
an elastic material and having a valve hole at center thereof,
wherein the sealing valve is mounted in an opening portion of a
container or a tube; and

a sleeve portion, provided to surround the opening portion
of the container or the tube, the sleeve portion being arranged
to press the sealing valve so as to press and hermetically seal
the valve hole of the sealing valve, wherein the sleeve portion
allows insertion of a tip end of a lock type syringe;

wherein when the tip end of the lock type syringe has been
inserted into the sleeve portion, the tip end of the lock type
syringe presses and deforms the sealing valve so as to open the
valve hole of the sealing valve, without running through the
sealing valve.


2. The connecting port for a syringe according to claim 1,
having either or both of a ring portion and a concave portion in
a surrounding area of the valve hole.



47




3. The connection port for a syringe according to claim 1,
wherein

a level of an upper end of the sealing valve is
substantially coincident with a position of an upper end of the
sleeve portion, and a cushion portion is provided in a lower
portion of the sealing valve, which is pressed and goes down
when a male connection port is inserted into the sleeve portion,
and brings the upper end of the sealing valve to a predetermined
position inside the sleeve portion when the lock type syringe
has been pulled out from the sleeve portion.


4. The connection port for a syringe according to claim 1,
comprising a cap member, attached to the opening portion, for
covering the sealing valve, the opening portion and the cap
member including attachment portions that are to be overlapped
in a vertical direction, each attachment portion having a ridge
portion and a valley portion that become convex or concave in
the vertical direction in such a manner that engagement of the
ridge portions and the valley portions between the opening
portion and the cap member prevents rotation of the cap member
together with the lock type syringe.



48




5. The connection port for a syringe according to claim 1,
comprising a cap member, attached to the opening portion, for
covering the sealing valve, the cap member being arranged to fit
into the opening portion in a radial direction of the opening
portion, each of the opening portion and the cap member
including a ridge portion and a valley portion that become
convex or concave in the radial direction at a fitting position
in the radial direction in such a manner that engagement of the
ridge portions and the valley portions between the opening
portion and the cap member prevents rotation of the cap member
together with the lock type syringe.


6. A mixed injection tube, comprising:

a sealing valve, which is an approximately semispherical
sealing valve, made of an elastic material and having a valve
hole at center thereof, the sealing valve is mounted to an
opening portion being formed at a center of a main body of the
mixed injection tube, the main body including connection ports
at both ends to each of which an infusion tube is to be
connected, and a channel, a cap member with a sleeve portion
provided on a ceiling of the cap member being mounted to the
opening portion of the main body, the mixed injection tube
characterized in that



49




the mixed injection tube comprises: a protruding stria
provided at a tip end on an outer circumferential surface of the
sleeve portion, with which a female screw structure formed on an
inner circumferential surface of a collar of a lock type syringe
is to be screwed; and

a resistance application portion, provided in a middle part
on the outer circumferential surface of the sleeve portion, for
temporarily stopping and holding a lock type syringe inserted
into the sleeve portion at an intermediate site of the sleeve
portion while the valve hole of the sealing valve is closed,

during insertion of the lock type syringe into the sleeve
portion, the lock type syringe is temporarily stopped at the
intermediate site of the sleeve portion by the resistance
application portion, and then, when a male connection port of
the lock type syringe is inserted into the sleeve portion more
deeply, a tip end of the male connection port presses and
deforms the sealing valve, thereby opening the valve hole of the
sealing valve.



50




7. The mixed injection tube according to claim 6, wherein

the resistance application portion is a second protruding
stria provided in the middle part on the outer circumferential
surface of the sleeve portion, screwed with a double thread
female screwing structure of the lock type syringe.


8. A connection tool for connecting to an infusion circuit
including one medical infusion line as a main line, a plurality
of other medical infusion lines, and a plurality of syringes,
comprising:

a main connection tube to be provided in a midway portion
of a tube of the one medical infusion line;

a plurality of branch connection tubes branching from a
surrounding area of the main connection tube; and

a plurality of connection ports according to claim 1,
wherein each of the connection ports is mounted in a top-end
opening portion of each of the branch connection tubes.


9. The connection tool for connecting to an infusion circuit
according to claim 8, wherein the branch connection tube is
provided with a linking portion for linking a tube of the other
medical infusion line or the syringe thereto.



51




10. A connection system for an infusion circuit, in which the
connection tool for an infusion circuit according to claim 8 is
attached to one medical infusion line, the valve hole of the
sealing valve mounted in each connection port of the connection
tool is opened by pressing and deforming the sealing valve by
means of a tube of the other medical infusion line or a tip end
of a syringe, without insertion of the tube of the other medical
infusion line or the syringe, to allow connection of the tube of
the other medical infusion line or the syringe to the one
medical infusion line.



52

Description

Note: Descriptions are shown in the official language in which they were submitted.



CA 02512775 2009-10-02

SEAL VALVE, CONNECTION PORT, MIX-FEED TUBE, CONNECTION DEVICE
FOR LIQUID INFUSION, CIRCUIT AND CONNECTION SYSTEM FOR LIQUID
INFUSION CIRCUIT THAT ARE FOR MEDICAL DEVICE

TECHNICAL FIELD

The present invention relates to a connection port provided
at an opening portion of a container or tube, for connecting a
lock needleless syringe to the container or tube. More
particularly, the present invention relates to a valve structure
of such a connection port.

BACKGROUND ART

Fig. 15 is a diagram of an infusion line for infusing blood
or drug solution through. a mixed injection tube for infusion.
The blood or drug solution is fed from an infusion solution

bottle or bag 300 through an infusion tube 301 to a catheter 303
connected to a connector 302. To one end of the infusion tube
301 is connected an introduction needle 304 to which a drip
chamber 305 for monitoring the flow rate of the blood or drug

solution is connected. Between the drip chamber 305 and the
connector 302, a flow rate adjuster 306, a desired number of
mixture injection tubes 307, an octopus tube 308 for removing
dust or air bubbles, and a filter 309 for preventing dust or the
like from passing therethrough are connected to the infusion
1


CA 02512775 2005-07-07

tube 301 (see Japanese Patent Laid-Open Publication No. Hei 8-
206230, Fig. 10, for example).

In the conventional mixed injection tube 307, as shown in
Fig. 16, a disc-shaped rubber plug 307c is arranged to air-
tightly fit into a branch tube portion 307b formed on a side of

a T-shaped mixed injection tube main body 307a, for example. A
cap 307d is provided to press the rubber plug 307c. The main
body 307a of the mixed injection tube 307 is inserted and
connected to a middle portion of an infusion tube 301 in an

infusion circuit (for example, a dialysis circuit for an
artificial kidney, or an intravenous circuit). The mixed
injection tube 307 is used for injecting blood or drug solution
in a main body of a syringe 310 to blood or drug solution
flowing in the infusion circuit, while a syringe needle 310a

attached to the syringe 310 is run through the rubber plug 307c
fitting in the branch tube portion 307b (see Japanese Patent
Laid-Open Publication No. 2002-306610, Fig. 28, for example).

Since this mixed injection tube 307 is used while the
syringe needle 310a is run through the disc-shaped rubber plug
307c, the use of the syringe needle 310a increases the cost.

Moreover, there is a risk that a doctor or nurse may stick the
syringe needle 310a into himself or herself by mistake to be
contaminated with pathogenic germs because of adhesion of blood.
In addition, in order to prevent pathogenic germs contamination
2


CA 02512775 2005-07-07

caused by adhesion of blood of a patient, a used syringe needle
310a has to be disposed appropriately without being used again.
The disposal of the used syringe needle 310a requires sufficient
attention so as not to cause a person who collects disused

articles to be improperly damaged by the syringe needle 310a or
contaminated with pathogenic germs. Furthermore, the misuse of
such a used syringe needle 310a may cause in-hospital infection.

As a connection structure that allows a syringe to be
connected without using a needle, the inventors of the present
application proposed a structure using a sealing valve made of

rubber (see Japanese Patent Laid-Open Publication No. 2002-
306610, Figs. 7 and 8, for example).

Moreover, in recent years, a lock type syringe has been
introduced in which a syringe needle is securely held by a
screwing structure.

Referring to Figs. 17a and 17b, a lock type syringe 400
includes a collar 402 surrounding a male connection port 401
(lure portion). In the inner circumferential surface of the
collar 402, a double thread female screwing structure 403 is

provided. The lock type syringe 400 is used while a syringe
needle 405 having a screwing piece 404 at its base end, that is
screwed with the double thread female screwing structure 403, is
connected to the male connection port 401, as shown in Figs. 17a
and 17c. In Figs. 17a and 17b, the reference numeral 406 denotes
3


CA 02512775 2005-07-07

a thread of the female screwing structure 403, 407 a piston of a
syringe, 408 a tapered insertion port of the syringe needle 405,
having a gradually reduced diameter, and 409 a cylinder portion
of the syringe. The male connection port (lure portion) 401 is

tapered in such a manner that its outer diameter is gradually
reduced from the base end to the top end, and fits with the
insertion port 408 of the syringe needle 405 at its tapered face.

As a structure that allows insertion of a lock type syringe
without using a needle (i.e., needleless) and also allows
opening and closing of a valve, a mixed injection tube has been

proposed that includes a valve structure employing a combination
of a float and a rubber button (see Japanese Patent Laid-Open
Publication No. 2000-354636, for example).

Japanese Patent No. 2954549 proposes connection of a lock
type syringe to a drug-solution bag or infusion tube, in a case
where drug solution or transfusion is extracted from or injected
to the drug-solution bag or the infusion tube that is used for
intravenous drip of drug solution or in dialysis treatment. In
this connection, the lock type syringe is used without a needle
screwed therewith (i.e., needleless).

DISCLOSURE OF THE INVENTION

According to one aspect, the present invention relates to a
sealing valve for a medical apparatus, made of an elastic
4


CA 02512775 2005-07-07

material and having have a valve hole at its center. The valve
hole of the sealing valve is opened by pressing and deforming
the sealing valve by means of a tip end of a male connection
port, without allowing the tip end of the male connection port
to run through the sealing valve.

The sealing valve of the present invention may be a sealing
valve that is made of an elastic material and is provided with
an approximately semispherical shape or a cylindrical shape with
a ceiling (including a shape in which the ceiling is

approximately semispherical or has an arched convex lower face
that protrudes downward), wherein a valve hole is provided at a
top of the sealing valve and is opened by pressing and deforming
the sealing valve by means of a tip end of a male connection
port, without allowing the tip end of the male connection port

to run through the sealing valve. Moreover, the sealing valve
for a medical apparatus of the present invention may include
either or both of a ring portion and a concave portion in a
surrounding area of the valve hole.

According to another aspect, the present invention relates
to a connection port in which a sealing valve for a medical
apparatus is mounted in an opening portion of the medical
apparatus and a sleeve portion is provided to surround the
opening portion of the medical apparatus. The sleeve portion is
arranged to press the sealing valve for the medical apparatus so
5


CA 02512775 2005-07-07

as to press and hermetically seal the valve hole of the sealing
valve for the medical apparatus, includes a screwing piece on
its outer circumferential surface, and allows a lock type
syringe to be inserted into and screwed with. In this connection

port, when the lock type syringe has been inserted into the
sleeve portion, a tip end of the lock type syringe presses and
deforms the sealing valve for the medical apparatus so as to
open the valve hole of the sealing valve for the medical
apparatus, without running through the sealing valve for the
medical apparatus.

In the connection port of the present invention, a level of
an upper end of the sealing valve for the medical apparatus may
be substantially coincident with a position of an upper end of
the sleeve portion, and a cushion portion may be provided in a

lower portion of the sealing valve, that is pressed and goes
down when a male connection port is inserted into the sleeve
portion, and brings the upper end of the sealing valve for the
medical apparatus to a predetermined position inside the sleeve
portion when the lock type syringe has been pulled out from the
sleeve portion.

The connection port of the present invention may include a
sleeve portion provided on its ceiling and a cap member,
attached to the opening portion of the medical apparatus, for
covering the sealing valve for the medical apparatus. The
6


CA 02512775 2005-07-07

opening portion and the cap member may include attachment
portions that are to be overlapped in a vertical direction, and
each attachment portion has a ridge portion and a valley portion
that become convex or concave in the vertical direction in such

a manner that engagement of the ridge portions and valley
portions between the opening portion and the cap member prevents
rotation of the cap member together with the lock type syringe.

The connection port of the present invention may include a
sleeve portion provided on its ceiling and a cap member,
attached to the opening portion of the medical apparatus, for

covering the sealing valve for the medical apparatus, the cap
member being arranged to fit into the opening portion in a
radial direction of the opening portion. Each of the opening
portion of the medical apparatus and the cap member may include

a ridge portion and a valley portion that become convex or
concave in the radial direction at a fitting position in the
radial direction in such a manner that engagement of the ridge
portions and the valley portions between the opening portion of
and the cap member prevents rotation of the cap member together
with the lock type syringe.

According to another aspect, the present invention relates
to a mixed injection tube in which a sealing valve for a medical
apparatus is mounted to an opening portion of a main body of the
mixed injection tube, the main body including connection ports
7


CA 02512775 2005-07-07

at both ends to each of which an infusion tube is to be
connected, and a channel having the opening portion at its
center. A cap member with a sleeve portion on its ceiling is
mounted to the opening portion of the main body. The mixed

injection tube includes: a protruding stria provided at a tip
end on an outer circumferential surface of the sleeve portion,
with which a female screw structure formed on an inner
circumferential surface of a collar of a lock type syringe is to
be screwed; and a resistance application portion, provided in a

middle part on the outer circumferential surface of the sleeve
portion, for temporarily stopping and holding a lock type
syringe inserted into the sleeve portion at an intermediate site
of the sleeve portion while the valve hole of the sealing valve
for the medical apparatus is closed. During insertion of the

lock type syringe into the sleeve portion, the lock type syringe
is temporarily stopped at the intermediate site of the sleeve
portion by the resistance application portion. Then, when a male
connection port of the lock type syringe is inserted into the
sleeve portion more deeply, a tip end of the male connection

port presses and deforms the sealing valve for the medical
apparatus, thereby opening the valve hole of the sealing valve.
According to another aspect, the present invention relates

to a connection tool for connecting, to one medical infusion
line as a main line, a plurality of other medical infusion lines
8


CA 02512775 2005-07-07

or a plurality of syringes. The connection tool includes: a main
connection tube to be provided in a midway portion of a tube of
the one medical infusion line; and a plurality of branch
connection tubes branching from a surrounding area of the main

connection tube, wherein a sealing valve for a medical apparatus
is mounted in a top-end opening portion of each of the branch
connection tubes.

According to another aspect, the present invention relates
to a connection system for an infusion circuit, in which the
aforementioned connection tool for an infusion circuit is

attached to one medical infusion line. A valve hole of the
sealing valve for the medical apparatus mounted in each
connection port of the connection tool is opened by pressing and
deforming the sealing valve for the medical apparatus by means

of a tube of the other medical infusion line or a tip end of a
syringe, without insertion of the tube of the other medical
infusion line or the syringe. Thus, the connection system allows
connection of the tube of the other medical infusion line or the
syringe to the one medical infusion line.


BRIEF DESCRIPTION OF THE DRAWINGS

Fig. la is a vertical cross-sectional view of a syringe
connection port according to one embodiment of the present
invention; and Fig. lb is a vertical cross-sectional view of the
9


CA 02512775 2005-07-07

syringe connection port shown in Fig. la when a lock needleless
syringe is screwed with the syringe connection port.

Fig. 2 is a vertical cross-sectional view of a modified
example of a sealing valve according to the present invention.

Fig. 3 is a vertical cross-sectional view of a syringe
connection port according to one embodiment of the present
invention.

Fig. 4 is a vertical cross-sectional view of a mixed
injection tube according to one embodiment of the present
invention.

Fig. 5a is a side view of the main body of the mixed
injection tube; and Fig. 5b is a vertical cross-sectional view
of a cap member.

Fig. 6 is a vertical cross-sectional view of a mixed
injection tube according to one embodiment of the present
invention.

Fig. 7a is a cross-sectional view of a branch channel of
the main body of the mixed injection tube, showing an engagement
groove, taken along the line A-A; and Fig. 7b is a front view of
the branch channel.

Fig. 8a is a vertical cross-sectional view of a cap member,
showing an engagement portion of the cap member; and Fig. 8b is
a bottom view of the cap member.

Fig. 9a is a vertical cross-sectional side view of a mixed


CA 02512775 2005-07-07

injection tube according to one embodiment of the present
invention; and Fig. 9b is a plan view of a sleeve portion
thereof.

Fig. 10 is a vertical cross-sectional side view showing a
state where a mixed injection tube according to one embodiment
of the present invention is used.

Fig. 11 is a vertical cross-sectional side view showing a
state where a mixed injection tube according to one embodiment
of the present invention is used.

Fig. 12a is a vertical cross-sectional view showing a
sealing valve according to one embodiment of the present
invention; and Fig. 12b is a plan view thereof.

Fig. 13 illustrates an exemplary configuration of an
infusion circuit using a connection tool for an infusion circuit
according to the present invention.

Fig. 14 shows a modified example of a sealing valve for a
medical apparatus according to the present invention.

Fig. 15 is a diagram of an infusion circuit according to
one embodiment of the present invention.

Fig. 16 is a vertical cross-sectional view of a
conventional mixed injection tube.

Fig. 17a is a vertical cross-sectional view of a typical
lock type syringe; Fig. 17b is a vertical cross-sectional view
of a male connection port thereof; and Fig. 17c is a vertical
11


CA 02512775 2005-07-07

cross-sectional view of a syringe needle of the lock type
syringe.

DETAILED DESCRIPTION OF THE INVENTION

Hereinafter, embodiments of the present invention will be
described in detail by way of example with reference to the
drawings.

First, an embodiment, in which a connection port of the
invention is applied to various mixed injection tubes, will be
described with reference to the drawings.

Referring to Figs. la and lb, a mixed injection tube 1
according to one embodiment of the present invention includes
infusion-tube connection ports 11 and 12 at both ends; a T-
shaped mixed injection tube main body 10 having a lumen that is

in communication with the infusion-tube connection ports 11 and
12; a branch tube portion 13 formed on a side of the mixed
injection tube main body 10, that is in communication with the
lumen; a sealing valve 20 mounted within the branch tube portion
13; and a cap 30 mounted to the branch tube portion 13.

In this embodiment, the branch tube portion 13 is provided
in a thinner portion 10a of the mixed injection tube main body
10 having a reduced thickness. That thickness is set so as not
to affect the strength of the mixed injection tube main body 10.
The branch tube portion 13 is provided with a collar 10b for
12


CA 02512775 2005-07-07

supporting the lower end of the sealing valve 20 mounted in the
branch tube portion 13.

The mixed injection tube main body 10, the branch tube
portion 13, and the sleeve portion 30 are formed of a polymeric
resin material, such as polyamide, polyvinyl chloride,
polypropylene, polyurethane, polycarbonate, and polyethylene.

The sealing valve 20 is formed of an elastic material to be
semispherical, and is arranged to air-tightly fit into the
branch tube portion 13 and be secured in the branch tube portion

13 with the cap 30. On an upper surface (top portion) of the
sealing valve 10, a concave portion 20a is formed for receiving
an orifice portion 401 of a lock type syringe 400. The concave
portion 20a has a valve hole 20b running therethrough vertically.

The valve hole 20b may be formed to be a slit, for example.
The valve hole 20b may be formed in any shape other than a slit-
like shape, so that it extends through the concave portion 20a
vertically. In this embodiment, the valve hole 20b can be formed
by sticking a straight or conical hole-formation tool into the
sealing valve 20 after the molding of the valve 20.

Alternatively, the valve hole 20b may be formed simultaneously
with the molding of the sealing valve 20.

The elastic material for the sealing valve 20 is formed by
a polymeric material, such as silicone rubber, natural rubber,
polyurethane, styrene-butadiene copolymer, acrylonitrile-
13


CA 02512775 2005-07-07

butadiene copolymer, and polyisoprene.

At the upper end of the branch tube portion 13, a convex
portion 13a for engagement is provided on the outer
circumferential surface. The cap 30 has an approximately T-

shaped cross-section, and is provided with a convex portion 30a
for engagement at the lower end of the cap 30 on the inner
circumferential surface, that is to engage with the branch tube
portion 13. The cap 30 is also provided with a concave arc-like
portion 30b having an inner surface with which the semispherical

sealing valve 20 comes into contact. The cap 30 is further
provided with a screwing piece 30d, with which a female screwing
structure 403 of a collar 402 of a syringe 400 is screwed, at
the upper end of the cylindrical sleeve portion 30c on the outer
circumferential surface in such a manner that the screwing piece
30d projects.

In this embodiment, the sealing valve 20 has an outer
diameter D1 (not shown) at a given position on the
circumferential surface of the convex arc-like portion thereof,
that is larger than an inner diameter D2 (not shown) at the

corresponding position on the concave arc-like portion 30b of
the cap 30 (i.e., D1 > D2). Thus, a predetermined amount of
interference (D1 - D2) is provided. When the sealing valve 20 is
placed within the sleeve portion 30c and the cap 30 is mounted
to the branch tube portion 13, a compressing force is caused to
14


CA 02512775 2005-07-07

act on the sealing valve 20, thereby the valve hole 20b of the
sealing valve 20 is always pressed and hermetically sealed.

The semispherical sealing valve 20 is deformed to expand
outward when receiving an internal pressure of blood or drug
solution. However, the valve hole 20b does not allow leak of

fluid therethrough caused by the internal pressure of blood or
drug solution.

The mixed injection tube 1 has a structure in which the
sealing valve 20 is placed within the branch tube portion 13 in
a liquid-tight manner. When the mixed injection tube 1 is used,

an infusion tube of an infusion circuit is inserted into each of
the infusion-tube connection ports 11 and 12 of the mixed
injection tube main body 10 so as to connect the mixed injection
tube 1 to a midway portion of the infusion circuit. The

insertion and connection of the infusion-tube connection ports
11 and 12 to the infusion tubes may be achieved by using
adhesive or simply by pressing the infusion tubes into the
connection ports 11 and 12 by using an elastic force of the
infusion tube.

In a case where a syringe 400 is connected to this mixed
injection tube 1, the orifice portion 401 of the syringe 400 is
inserted into the sleeve 30c of the cap 30, and then the female
screwing structure 403 formed on an inner surface of the collar
402 of the syringe 400 is screwed with the screwing piece 30d


CA 02512775 2005-07-07

formed at the upper end on the outer circumferential surface of
the sleeve portion 30c. Then, as shown in Fig. lb, the leading
end of the orifice portion 401 of the syringe 400 directly
presses the sealing valve 20 so as to deform the sealing valve

20. By completely screwing (locking) the female screwing
structure 403 and the screwing piece 30d together, the valve
hole 20b of the sealing valve 20 can be opened. Moreover, by
doing this, the syringe 400 is held by the sleeve portion 30c,
thus maintaining the state where the valve hole 20b is opened.

As described above, the sealing valve 20 allows the valve
hole 20b to be opened, without making the tip end of the male
connection port of the syringe 400, such as the orifice portion
401, run through the sealing valve 20, by allowing the tip end
of the male connection port of the syringe 400 to press and
deform the sealing valve 20.

Then, by pushing a piston 407 of the syringe 400 into a
cylinder portion 409, blood or drug solution in the cylinder
portion 409 can be injected into blood or drug solution in the
infusion circuit through the mixed injection tube 1. If

necessary, blood or drug solution in the infusion circuit can be
extracted into the cylinder portion 409 of the syringe 400
through the mixed injection tube 1.

Next, a modification of the sealing valve 20 is described.
A semispherical sealing valve 21 shown in Fig. 2 is
16


CA 02512775 2005-07-07

provided with a ring portion 21d having a predetermined height
at the top thereof in order to come into contact with an orifice
portion 401 of a syringe 400 and a concave portion 21e having a
predetermined depth.

This sealing valve 21 includes the ring portion 21d having
a predetermined height at its top, and therefore is pressed down
by the orifice portion 401 of the syringe 400 to a lower level
by a depth corresponding to the height of the ring portion 21d.
Moreover, since the sealing valve 21 includes the concave

portion 21e, the thickness of a portion of the sealing valve 21
where a valve hole 21b is provided is reduced. When a syringe
400 is connected to the mixed injection tube, this sealing valve
21 allows the valve hole 21b to be opened wider and more
securely because of cooperation of the ring portion 21d and the

concave portion 21e, as compared with the sealing valve 20 shown
in Fig. 1. Although a case where both the ring portion 21d and
concave portion 2le are provided achieves the best opening
operation, either the ring portion 21d or concave portion 21e
may be provided.

In the mixed injection tube 1 of the embodiment shown in
Fig. 1 and the modified mixed injection tube 1 shown in Fig. 2,
the valve hole 20b or 21b is always pressed and hermetically
sealed by an elastic force of the sealing valve 20 or 21 and a
fastening pressure applied by the cap 30, as described above,
17


CA 02512775 2005-07-07

thereby preventing leak of blood or drug solution. Moreover, by
screwing the collar 402 of the syringe 400 and the screwing
piece 30d of the sleeve portion together, i.e., locking them,
the orifice portion 401 of the syringe 400 can press and deform

the sealing valve 20 or 21 without running through the valve
hole 20b or 21b of the sealing valve 20 or 21, thereby opening
the valve hole 20b or 21b. Thus, in this state, it is possible
to inject blood or drug solution in the syringe 400 into blood
or drug solution in an infusion circuit and, if necessary, to

extract blood or drug solution in the infusion circuit into the
syringe 400. Furthermore, when the screwing of the syringe 400
and the sleeve portion 30c is released, the sealing valve 20 is
brought back to its original state, i.e., a state where it is
semispherical or approximately semispherical, as shown in Fig.

la or 2, because of resilience of the sealing valve 20 or 21,
thereby pressing and hermetically sealing the valve hole 20b
with a fastening force from the cap 30 again. Thus, leak of
blood or drug solution can be prevented.

Next, another embodiment of the present invention is
described.

As shown in Fig. 3, this mixed injection tube la includes a
sealing valve 64 placed on the collar portion 10b of the mixed
injection tube main body 10. A cap 38 is arranged to fit into
the branch tube portion 13 of the mixed injection tube main body
18


CA 02512775 2005-07-07

10. At the upper end on the outer circumferential surface of the
branch tube portion 13, a convex portion 13a for engagement is
formed. The cap 38 includes a convex portion 38a for engagement
at its lower end on the inner circumferential surface, a sleeve

portion 38b, a screwing piece 38c at the upper end on the outer
circumferential surface of the sleeve portion 38b, a collar
portion 38d at the upper end on the inner surface of the sleeve
portion 38b, and a portion 38e formed between the inner end of
the collar portion 38d and the inner surface of the sleeve

portion 38b, which has a concave arc-like cross section. The
sealing valve 64 includes a cushion portion 64a that broadens
downward like a horn, a cylindrical portion 64b continuing from
the cushion portion 64a, a semispherical head 64c continuing
from the cylindrical portion 64b, a ring portion 64d formed on

the head 64c, and a valve hole 64e formed at the center of the
ring portion 64d.

The mixed injection tube la according to this embodiment
always presses the sealing valve 64 up by a cushion effect of
the cushion portion 64a. Thus, the semispherical head 64c is

pressed against the concave arc-like portion 38e of the cap 38
and therefore a fastening force from the concave arc-like
portion 38e is applied to the head 64 so as to press and
hermetically seal the valve hole 64e. When an orifice portion
401 of a syringe 400 is inserted into the sleeve portion 38b of
19


CA 02512775 2005-07-07

the cap 38 and a female screwing structure 403 of a collar 402
is screwed with the screwing piece 38c of the cap 38, the
cushion portion 64a of the sealing valve 64 is pressed down
against its elastic force and therefore the head 64c of the

sealing valve 64 is released from the fastening force applied by
the concave arc-like portion 38e of the cap 38. As a result, the
valve hole 64e of the sealing valve 64 is opened.

In this embodiment, a connection port is formed in such a
manner that a level of an upper end of a sealing valve for a
medical apparatus is substantially coincident with a position of

a top end of a sleeve portion and a cushion portion is provided
in a lower portion of that sealing valve, which is pressed down
when a male connection port is inserted into the sleeve portion
and brings the upper end of the sealing valve back to a

predetermined position within the sleeve portion when a lock
type syringe is pulled out from the sleeve portion. As described
above, such a connection port can position the upper end of the
sealing valve near the upper end of the sleeve portion and can
ensure the large amount of deformation of the sealing valve when

an orifice portion of a lock needleless syringe is inserted into
the sleeve portion. Moreover, when the orifice portion of the
lock needleless syringe is pulled out from the sleeve portion,
the sealing valve brings the level of the upper end thereof to a
position near the upper end of the sleeve portion because of


CA 02512775 2005-07-07

resilience of the cushion portion. Thus, in this sealing valve,
the level of the upper end is substantially coincident with the
position of the upper end of the sleeve portion after the
orifice portion of the lock needleless syringe was pulled out

from the sleeve portion. Therefore, even if blood or drug
solution adheres to an upper portion of the sealing valve, it is
possible to clean away the adhering blood or drug solution
easily and surely.

Next, another embodiment of the present invention will be
described.

As shown in Fig. 4, a mixed injection tube lb includes a
mixed injection tube main body 71 that is connected to an
infusion tube, a sealing valve 72 mounted to the mixed injection
tube main body 71 for preventing leak of fluid, and a cap member

74 having a sleeve portion 73 with which a lock type syringe 400
(see Fig. 17b) is screwed.

The mixed injection tube main body 71 is a tube to be
connected to a midway portion of the infusion tube and includes
connecting portions 81 and 82 at both ends, to each of which the

infusion tube can be connected, as shown in Figs. 4 and 5a.
Inside the mixed injection tube main body 71 is formed a main
channel 83 which has a branch portion 84 at its center. An
opening portion 86 is formed above the mixed injection tube main
body 71 in such a manner that an opening of the opening portion
21


CA 02512775 2005-07-07

86 faces the branch portion 84. The opening portion 86 is
provided with a seat portion 87 surrounding the opening, onto
which the sealing valve 72 can be placed. On the upper end
surface of the opening portion 86, a ridge portion 88 and a

valley portion 89 that are alternately formed continuously in
the circumferential direction. The ridge portion 88 protrudes
upward, while the valley portion 89 becomes concave downward, as
shown in Fig. 5a. The end of the ridge portion 88 is formed to
dwindle. Moreover, an engagement portion 90 to be engaged with

the cap member 74 is provided on the outer circumferential
surface of the opening portion 86 so as to protrude outward in
the radial direction.

The cap member 74 is a member mounted to the opening
portion 86 of the mixed injection tube main body 71 to cover the
opening portion 86, as shown in Figs. 4 and 5b, and includes: a

base portion 91 in a form of a substantially disc, that is to be
mounted to the opening portion 86 of the mixed injection tube
main body 71; and a sleeve portion 73 extending through the
center of the base portion 91 to protrude vertically. An outer

circumferential edge 92 of the base portion 91 extends downward
along the outer circumferential edge of the opening portion 86
of the mixed injection tube main body 71, and is provided with
an engagement portion 93 at its lower end. The engagement
portion 93 protrudes inward in the radial direction and can
22


CA 02512775 2005-07-07

engage with the engagement portion 90 of the main body 71. The
sleeve portion 73 of the cap member 74 has an inner diameter
that allows insertion of a male connection port 401 of a lock
type syringe 400 (see Fig. 17b) thereinto, and includes a

screwing piece 94 at its upper end, with which a female screw
portion 403 of the lock type syringe 400 may be screwed.
Moreover, the sleeve portion 73 of the cap member 74 has a
pressing face 97 inside the upper portion of the sleeve portion
73. The pressing face 97 has a spherical shape with an inner
diameter gradually reduced upward.

On the lower surface of the cap member 74, a ridge portion
95 that protrudes downward and a valley portion 96 that becomes
concave upward are alternately formed continuously in the
circumferential direction in such a manner that the valley

portion 96 and the ridge portion 95 correspond to the ridge
portion 95 and the valley portion 96 formed on the upper surface
of the branch portion 84 of the main body 71, as shown in Fig.
5b. The tip end of the ridge portion 95 is formed to dwindle in
size.

The sealing valve 72 includes a base portion 101 in a form
of a disc, that may be placed on the seat portion 87 provided in
the opening portion 86 of the mixed injection tube main body 71;
and a protruding portion 102 at the center of the base portion
101, that protrudes upward inside the sleeve portion 73 of the
23


CA 02512775 2005-07-07

cap member 74. The protruding portion 102 of the sealing valve
72 has a semispherical vertical cross-section at its upper end,
and has a small-diameter hole (valve hole) 103 formed at its
center. The sealing valve 72 is provided with a pressed face 104

in the upper portion of the protruding portion 102. The pressed
face 104 is approximately spherical and has radius of curvature
that is slightly larger than that of the pressing face 97
provided inside the sleeve portion 73 of the cap member 74.

The sealing valve 72 is mounted between the seat portion 87
of the mixed injection tube main body 71 and the cap member 74
by mounting the cap member 74 to the branch portion 84 of the
mixed injection tube main body 71 while the base portion 101 is
placed on the seat portion 87 of the mixed injection tube main
body 71 and the protruding portion 102 is mounted within the

sleeve portion 73 of the cap member 74. In this state, the
protruding portion 102 of the sealing valve 72 is pressed to
enter the inside of the sleeve portion 73 of the cap member 74,
so that the pressed face 104 in the upper portion of the
protruding portion 102 is pressed by the pressing face 97 inside

the sleeve portion 73 of the cap member 74in the radial
direction. Thus, the small-diameter hole (valve hole) 103 formed
at the center of the upper end of the protruding portion 102 is
always pressed and hermetically sealed.

In this mixed injection tube lb, the ridge portion 88
24


CA 02512775 2005-07-07

protruding upward and the valley portion 89 that becomes concave
downward are alternately formed on the upper end surface of the
opening portion 86 of the mixed injection tube main body 71 so
as to continue from each other in the circumferential direction,

while the valley portion 96 that becomes concave upward and the
ridge portion 95 protruding downward are alternately formed on
the lower surface of the cap member 74 continuously in the
circumferential direction in such a manner that they correspond
to the ridge portion 88 and the valley portion 89 of mixed

injection tube the main body 71, respectively. Thus, when the
cap member 74 is mounted to the branch portion 84 of the mixed
injection tube main body 71, the ridge portion 95 and valley
portion 96 of the cap member 74 fit with the valley portion 89
and ridge portion 88 of the main body 71, respectively, in the
mounting direction, i.e., a vertical direction.

Even if the position of the ridge portion 95 of the cap
member 74 is not aligned with that of the valley portion 89 of
the mixed injection tube main body 71 in the mounting of the cap
member 74 to the opening portion 86 of the mixed injection tube

main body 71, the ridge portion 95 of the cap member 74 slides
on the ridge portion 88 of the mixed injection tube main body 71,
thereby the position of the ridge portion 95 of the cap member
74 is automatically adjusted. Thus, the ridge portion 95 of the
cap member 74 can fit into the valley portion 89 of the mixed


CA 02512775 2005-07-07

injection tube main body 71. Therefore, it is unnecessary to
align the cap member 74 and the mixed injection tube main body
71 in the circumferential direction when the cap member 74 is
mounted to the opening portion 86 of the mixed injection tube
main body 71, providing excellent workability.

Moreover, when a lock type syringe 400 is screwed with the
sleeve portion 73 of the cap member 74, the cap member 74 cannot
rotate together with the lock type syringe 400. Therefore, it is
possible to smoothly attach the lock type syringe 400 to the cap

member 74 by screwing. When the lock type syringe 400 is
detached from the cap member 74, excellent workability can be
provided because the cap member 74 cannot rotate together with
the lock type syringe 400.

In the mixed injection tube lb, when the lock type syringe
400 is screwed with the sleeve portion 73 of the cap member 74,
the protruding portion 102 of the sealing valve 72 is pressed
downward to be deformed, thereby the small-diameter hole (valve
hole) 103 is released from the hermetically sealed state. Thus,
while the lock type syringe 400 is screwed with the sleeve

portion 73 of the cap member 74, it is possible to extract drug
solution and/or inject infusion between the mixed injection tube
10 and the lock type syringe 400.

Moreover, when the lock type syringe 400 has been detached from
the sleeve portion 73 of the cap member 74, the protruding
26


CA 02512775 2005-07-07

portion 102 of the sealing member 72 goes back to the inside of
the sleeve portion 73 of the cap member 74 because of resilience
of the sealing valve 72 and the small-diameter hole (valve hole)
103 is also brought back to its original state in which it is

pressed and hermetically sealed. Thus, drug solution inside the
mixed injection tube lb cannot leak outside.

Next, a mixed injection tube is according to another
embodiment of the present invention is described.

This mixed injection tube lc includes a connecting portion
to which a tube connector 111 can be connected. The tube
connector 111 is an exemplary male medical apparatus having a
female screw structure on an inner circumferential surface of a
collar surrounding a male connection port, like a lock type
syringe 400, as shown in Fig. 6.

The tube connector 111 includes a connector main body 112
and a collar member 113 mounted to the connector main body 112.
The connector main body 112 has a male connection port 114 at
its tip end, a hub portion 115 having an increased outer
diameter in its middle portion, and a connecting portion 117 at

its base end, to which a tube 116 can be connected. The hub
portion 115 in the middle part has an increased outer diameter
and has an engagement portion 118 at an end closer to the base
end of the connector main body 112, with which the collar member
113 is engaged. The collar member 113 is a member covering the
27


CA 02512775 2005-07-07

connector main body 112 and includes a female screw structure
120 on its inner circumferential surface. The base end of the
collar member 113 is provided with an engagement portion 119
that is to engage with the engagement portion 118 of the

connector main body 112. The engagement portion 119 is arranged
to protrude inward.

The mixed injection tube lc includes a mixed injection tube
main body 121 to be connected to an infusion tube, a sealing
vale 122, mounted to the mixed injection tube main body 121, for

preventing leak of fluid, and a cap member 123 with which the
tube connector 111 can be screwed, as shown in Fig. 6.

As shown in Fig. 6, the mixed injection tube main body 121
is a tube connected to a midway portion of the infusion tube and
includes connecting portions 131 and 132 at both ends, to each

of which the infusion tube can be connected. A main channel 133
is formed inside the mixed injection tube main body 121 and a
branch portion 134 is provided at the center of the main channel
133. The mixed injection tube main body 121 also includes a
plurality of branch channels 135 that are in communication with

the branch portion 134 with a predetermined space in the
circumferential direction. Please note that two branch channels
135 are provided along a straight line crossing the main channel
133 at a right angle in the shown example.

The upper end (tip end) of the branch channel 135 serves as
28


CA 02512775 2005-07-07

a seat portion 136 on which the sealing valve 122 is placed. On
the outer circumferential surface of the branch channel 135, an
engagement groove 138 into which an engagement portion 137 (see
Fig. 8b) of the cap member 123 described later can fit in the

radial direction is formed. In the engagement groove 138, a
ridge portion 139 protruding in the radial direction and a
valley portion 140 that becomes concave in the radial direction
are formed alternately and continuously in the circumferential
direction, as shown in Figs. 7a and 7b. An end of the ridge
portion 139 is formed to dwindle.

The cap member 123 is a member to be mounted to an upper-
end opening 141 of the branch channel 135 of the mixed injection
tube main body 121 so as to cover that upper-end opening 141, as
shown in Figs. 8a and 8b. The cap member 123 includes a pipe-

like portion 142 that is to be mounted on the outer surface of
the upper portion of the branch channel 135, and an
approximately semispherical portion 143 for covering the upper-
end opening 141 of the branch channel 135. The cap member 123 is
provided with a screwing piece 144 with which the female screw

structure 120 of the tube connector 111 is screwed, on the outer
circumferential surface in such a manner that the screwing piece
144 protrudes outward in the radial direction.

At the lower end of the pipe-like portion 142 of the cap
member 123, an engagement portion 137 is provided on its inner
29


CA 02512775 2005-07-07

circumferential surface to protrude inward in the radial
direction, which can fit into the engagement groove 138 of the
branch channel 135. In this engagement portion 137, a valley
portion 146 that becomes concave in the radial direction, i.e.,

the mounting direction of the engagement portion 137 to the
engagement groove 138, and a ridge portion 147 that protrudes in
the radial direction are alternately formed in the
circumferential direction continuously so as to correspond to
the ridge portion 139 and valley portion 140 of the engagement

groove 138, respectively, as shown in Figs. 8a and 8b. An end of
the ridge portion 147 is formed to dwindle.

Moreover, the inner circumferential surface of the approximately
semispherical portion 143 of the cap member 123 serves as a
pressing face 148 that presses the sealing valve 122, described

later, inward in the radial direction. In addition, an insertion
port 149 into which the male connecting portion 114 of the tube
connector 111 can be inserted is provided at a top portion of
the approximately semispherical portion 143 of the cap member
123.

The sealing valve 122 is an approximately semispherical
member that can be placed on the seat portion 136 provided at
the upper end of the branch channel 135 of the mixed injection
tube main body 121, and is provided with a small-diameter hole
(valve hole) 151 at its top portion.



CA 02512775 2005-07-07

This sealing valve 122 is mounted between the seat portion
136 provided at the upper end of the branch channel 135 of the
mixed injection tube main body 121 and the cap member 123 by
mounting the cap member 123 to the branch channel 135 of the

main body 121 while the sealing valve 122 is placed on the seat
portion 136. The outer circumferential surface 152 of the
sealing valve 122 is slightly larger than the inner
circumferential surface of the cap member 123. Thus, when the
cap member 123 is mounted, the outer circumferential surface of

the sealing valve 122 is pressed inward in the radial direction
by the inner circumferential surface of the cap member 123. This
pressing force compresses and deforms the top portion of the
sealing valve 122 inward in the radial direction. Therefore, the
small-diameter hole (valve hole) 151 formed in the top portion

of the sealing valve 122 is always pressed and hermetically
sealed.

In this mixed injection tube lc, when the cap member 123 is
mounted to the branch channel 135 of the mixed injection tube
main body 121, the ridge portion 147 and the valley portion 146

of the engagement portion 137 of the cap member 123 fit with the
valley portion 140 and the ridge portion 139 of the engagement
groove 138 of the branch channel 135, respectively, in a
direction in which the engagement portion 145 of the cap member
123 fits into the engagement groove 138 of the branch channel
31


CA 02512775 2005-07-07
135, i.e., the radial direction.

In this mounting, even if the ridge portion 147 of the cap
member 123 is not aligned with the valley portion 140 of the
branch channel 135, the ridge portion 147 of the cap member 123

slides on the ridge portion 139 of the branch channel 135,
thereby the position of the ridge portion 147 of the cap member
123 is automatically adjusted. Thus, the ridge portion 147 of
the cap member 123 fits into the valley portion 140 of the
branch channel 135. Therefore, it is unnecessary to align the

cap member 123 and the branch channel 135 in the circumferential
direction, providing excellent workability.

Moreover, when the collar member 113 of the tube connector
111 is screwed with the sleeve portion 142 of the cap member 123,
the cap member 123 cannot rotate together with the collar member

113 because the ridge portion 147 and the valley portion 146 of
the cap member 123 engage with the valley portion 140 and the
ridge portion 139 of the main body 121 in the circumferential
direction, respectively. Thus, it is possible to smoothly attach
the collar member 113 of the tube connector 111 by screwing.

Similarly, when the tube connector 111 is detached, the cap
member 123 cannot rotate together with the collar member 113 of
the tube connector 111. Therefore, excellent workability can be
achieved in this detaching.

The mixed injection tube 1c has a structure in which, when
32


CA 02512775 2005-07-07

the collar member 113 of the tube connector 111 is screwed with
the cap member 123, the male connection port 114 of the tube
connector 111 presses the top portion of the sealing valve 122
downward so as to release the small-diameter hole (valve hole)

151 from the state in which it is pressed and hermetically
sealed. Thus, while the tube connector 111 is screwed with the
cap member 123 and the male connection port 114 of the tube
connector 111 presses the top portion of the sealing valve 122
downward, extraction or injection of drug solution can be made

between the mixed injection tube lc and the tube connector 111.
Moreover, when the tube connector 111 has been detached from the
cap member 123, the top portion of the sealing valve 122 goes
back to the inside of the cap member 123 because of resilience
of the sealing valve 122, as shown in Fig. 6. The small-diameter

hole (valve hole) 151 also goes back to the state where it is
pressed and hermetically sealed. Thus, drug solution in the
mixed injection tube lc cannot leak outside.

Although an embodiment of the present invention has been
described above, the present invention is not limited thereto.

In the above embodiment, each of the ridge portions
provided on the mixed injection tube main body and the cap
member, is formed to have a triangular top end that dwindles.
Alternatively, the ridge portion may have a dwindling top end
that is curved like an arc.

33


CA 02512775 2009-10-02

Next, another embodiment of the present invention is
described.

In Fig. 9 showing a mixed injection tube ld according to
this embodiment, the reference numeral 161 denotes a mixed
injection tube main body, 162 a sealing valve, 163 a cap member,

164 and 165 connection ports, respectively, 166 a channel, 167
an opening portion, 168 a seat portion, 170 a mounting portion,
171 a flange, 172 a valve hole, 173 a sleeve portion, 174 a
protruding stria (first protruding stria, screwing piece), and
175 a cylindrical portion.

The mixed injection tube ld includes the second protruding
stria 181 provided as a resistance application portion for
temporarily stopping and holding a lock type syringe 400
inserted into the sleeve portion 173 at an intermediate site of

the sleeve portion 173, on the outer circumferential surface of
the middle part of the sleeve portion 173 so as to protrude. A
female screw structure 403 of the lock type syringe 400 will be
screwed with that second protruding stria 181, as shown in Fig.
9. In this embodiment, the sealing valve 162 is formed to have a

cylindrical shape having an approximately semispherical ceiling.
The position at which the second protruding stria 181 is
provided is set in such a manner that, when a leading end of a
male connection port 101 of a lock type syringe 400 that is
screwed with and inserted into the sleeve portion 173 has come
34


CA 02512775 2005-07-07

into contact with the approximately semispherical ceiling of the
sealing valve 162, a tip end of a thread of a female screw
structure 403 of the lock type syringe 400 reaches the second
protruding stria 181, as shown in Fig. 9. In this embodiment,

the second protruding stria 181 is arranged at positions shifted
from the protruding stria 174 provided at the top end of the
sleeve portion 173 by 90 degrees. In Fig. 9a, 10 and 11, the
second protruding stria 181 is shown with broken line below the
first protruding stria 174 for convenience of the description,

although the second protruding stria 181 does not actually
appear in the drawing because it is arranged on the front and
rear sides of the drawing.

In this embodiment, when a lock type syringe 400 is held at
the intermediate site of the sleeve portion 173 by the second
protruding stria 181, the leading end of the male connection

port 401 of the lock type syringe 400 is pressed against the
approximately semispherical ceiling of the sealing valve 162 so
as to elastically deform an upper portion of the sealing valve
162. In this state, deformation of the sealing valve 162 in the

radial direction is restricted by the inner circumferential
surface of the sleeve portion 173. Thus, an elastic reaction
force (compressive stress) is generated within that member,
which generates a strong sealing force at the valve hole.

Next, an operation in a case where injection or extraction


CA 02512775 2005-07-07

of drug solution is conducted by using a lock type syringe 400
will be described.

In this case, an operator inserts the lock type syringe 400
while screwing the lock type syringe 400 with the protruding
stria 174 at the tip end of the sleeve portion 173. Then, as

shown in Fig. 10, at the intermediate site of the sleeve portion
173, the thread of the female screw structure 403 of the lock
type syringe 400 comes into contact with the second protruding
stria 181 of the sleeve portion 173. At this position, the

female screw structure 403 of the lock type syringe 400 has not
been screwed with the second protruding stria 181, yet. Thus,
the operator can sense insertion resistance of the lock type
syringe 400 and can stop and hold the lock type syringe 400 at
the intermediate site of the sleeve portion 173 temporarily.

In this state, the leading end of the male connection port
101 of the lock type syringe 400 is pressed against the
approximately semispherical ceiling of the sealing valve 162 and
the upper portion of the sealing valve 162 is elastically
deformed slightly, thereby a strong sealing force is generated

at the valve hole 172 because of elastic reaction force of the
sealing valve.

Then, when the operator applies a force consciously to
further screw the lock type syringe 400 with the sleeve portion
173, as shown in Fig. 11, a collar 402 of the lock type syringe
36


CA 02512775 2005-07-07

400 and the sleeve portion 173 are elastically deformed and a
thread 406 starts to be screwed with the second protruding stria.
Thus, the male connection port 401 of the lock type syringe 400
is further inserted into the sleeve portion 173 more deeply. As

that insertion proceeds, the leading end of the male connection
port 401 of the lock type syringe 400 presses and deforms the
sealing valve 162 downward below the sleeve portion 173, so that
the valve hole 172 of the ceiling is opened.

The operator can open the valve hole 172 by screwing the
lock type syringe 400 with the sleeve portion 173 deeply. Thus,
the operator can inject or extract drug solution.

Then, in order for the operator to close the valve opening
172 of the sealing valve 162, the lock type syringe 400 is
rotated in the reverse direction to go toward a direction in

which the lock type syringe 400 is detached from the sleeve
portion 173 (opposite to the direction of insertion). In this
detaching, when the operator brings the lock type syringe 400
back to the intermediate site of the sleeve portion 173, as
shown in Fig. 10, the valve hole 172 of the sealing valve 162 is
closed.

Thus, the operator can temporarily stop the rotation of the
lock type syringe 400 at the intermediate site of the sleeve
portion 173 and hold the lock type syringe 400 at that
intermediate site. Then, in a case of injecting drug solution,
37


CA 02512775 2005-07-07

the lock type syringe 400 is screwed with the sleeve portion 173
deeply and then injection is performed. In a case of
interrupting the injection of drug solution, the operator can
bring the lock type syringe 400 back to the intermediate site of

the sleeve portion 173 and hold the lock type syringe 400 there.
As described above, according to this mixed injection tube
ld, in a case of intermittently injecting drug contained in the
syringe 400 every a predetermined time in such a manner that
fixed quantity of drug is injected in each injection, it is

possible to use the syringe 400 without pulling the syringe 400
out from the sleeve portion 173 but by inserting the syringe 400
into the sleeve portion 173 deeply at appropriate timings. In
other words, the syringe 400 cannot be pulled out in each
injection of drug. Thus, during injection of the fixed quantity

of drug, any germ or the like cannot enter the drug and fluid to
be injected cannot leak outside. Therefore, it is possible to
use the syringe 400 hygienically.

The embodiment has been described above in which, in a case
of injecting or extracting drug solution with the lock type
syringe 400, the syringe can be stopped temporarily in the

intermediate portion of the sleeve portion and can be used
without being pulled out from the sleeve portion when fixed
quantity of drug solution is injected. However, the resistance
application portion, provided in the sleeve portion, for
38


CA 02512775 2005-07-07

temporarily stopping the syringe in the intermediate portion of
the sleeve portion is not limited to the above embodiment.

As another embodiment of the resistance application portion,
a site having an increased outer diameter may be provided on the
outer circumferential portion of the middle part of the sleeve

portion, in such a manner that that site comes into contact with
the thread of the female screw structure of the lock type
syringe and applies the insertion resistance to the lock type
syringe (by resistance when the thread of the female screw

structure of the lock type syringe runs onto that site). In this
case, when the operator sensed such insertion resistance, the
operator temporarily stops the lock type syringe at the
intermediate site of the sleeve portion and holds the lock type
syringe at the intermediate site of the sleeve portion.

Next, a modified example of the sealing valve according to
the present invention will be described.

As the sealing valve of the present invention, an
approximately semispherical sealing valve (see Fig. 1) and a
sealing valve in a form of a cylinder having an approximately

semispherical ceiling (see Fig. 4) were described above. However,
the sealing valve of the present invention is not limited those
embodiments. For example, a sealing valve may be formed to be
cylindrical with an approximately flat ceiling, as shown in Fig.
12.

39


CA 02512775 2009-10-02

In a mixed injection tube if shown in Fig. 12a, a sealing
valve 191 is formed to be cylindrical with an approximately flat
ceiling. In Fig. 12a, the reference numeral 190 denotes a
connection port to which a syringe or connector is connected,
189 a sleeve portion, and 188 a screwing piece.

This sealing valve 191 is formed in such a manner that the
ceiling with a valve hole 192 formed therein has an arched
concave upper face 193 and an arched convex lower face 193L that
becomes convex downward. Moreover, the cylindrical portion of

the sealing valve 191 is formed to increase its thickness
downward.

An engagement concave groove 195 is formed near an upper
end on an inner circumferential surface of a branch connection
tube 194, and a stepped portion 196 is formed below that groove

195. The sealing valve 191 can be freely mounted to and detached
from the branch connection tube 194 by placing a ring-like
fixing tool 198 with a protrusion 197 formed on the outer
circumferential surface, which is to fit into the engagement
concave groove 195 of the branch connection tube 194, in such a

manner that the protrusion 197 fits into the engagement concave
groove 195.

The sealing valve 191 that is approximately cylindrical
with a ceiling is always compressed downward by a pressing force
applied by a lower face 199 of the ring-like fixing tool 198,


CA 02512775 2005-07-07

and the valve hole 192 is pressed and hermetically sealed by a
force (fastening force) directing toward the center of the
ceiling of the sealing valve 191 within the ceiling. Then,
although not shown, the valve hole 192 of the sealing valve 191

can be opened by inserting a connector or an orifice portion of
a lock type syringe into the branch connection tube 194 to press
and deform the sealing valve 191. That is, the valve hole 192
can be opened without insertion of a tip end of a connector or
an orifice portion of a lock type syringe into the valve hole
192 of the sealing valve 191.

When the leading end of the connector or the orifice
portion of the lock type syringe has been pulled out, the
sealing valve 191 brings its shape back into its original shape
due to resilience of the sealing valve 191, and therefore the

valve hole 192 is closed. In addition, the level of the ceiling
of the sealing valve 191 goes back to a position near the upper
end of the ring-like fixing tool 198. Therefore, it is easy to
clean away infusion drops that may remain on the sealing valve
191.

Furthermore, in an embodiment of a connection tool for an
infusion circuit, that uses this sealing valve, it is possible
to arrange the sealing valve 191 in such a manner that the
sealing valve 191 can be mounted and detached freely by means of
the ring-like fixing tool 198. Thus, the sealing valve 191 may
41


CA 02512775 2005-07-07

be detached during an initial mounting of the sealing valve 191,
an operation for replacing the sealing valve 191, and
sterilization of the connection tool.

Next, a connection tool for an infusion circuit according
to an embodiment of the present invention is described.

The connection tool for an infusion circuit according to
the present invention includes, as in the connection tool shown
in Fig. 6, a main connection tube 111 arranged in a middle part
of one tube of one medical infusion line; and a plurality of

branch connection tubes 135 branching from the surrounding area
of the main connection tube 111, and has a feature that a
sealing valve 122 for a medical apparatus is mounted to a top-
end opening portion of each branch connection tube 135. Moreover,
that connection tool also has a feature that the branch

connection tube 135 is provided with a linking portion 144 for
linking a tube of another medical infusion line or a syringe
thereto. Although two connection ports are provided in the
connection tool shown in Fig. 6, a plurality of connection ports
may be provided for the main connection tube 111.

The connection tool for an infusion circuit includes a
plurality of connection ports in the surrounding area of the
main connection tube, in each of which the sealing valve made of
rubber, with a valve hole at the center thereof, is mounted. The
valve hole is always pressed and hermetically sealed. Thus, a
42


CA 02512775 2005-07-07

plurality of tubes in other medical infusion lines (e.g. lateral
infusion lines) and/or syringes can be connected to that
connection tool. Therefore, it is possible to easily form a
complicated infusion circuit.

Moreover, since the rubber sealing valve with the valve
hole formed at the center thereof, that is always pressed and
hermetically sealed, is mounted to the connection port, an
operation for connecting or detaching a tube for another medical
infusion line or a syringe to/from the connection port without

using a needle can be done easily. In other words, an infusion
circuit can be opened only by connecting a tube of another
medical infusion line or a syringe to that connection port and
can be closed only by pulling the tube or syringe out from the
connection port. Moreover, in a case where a pinchcock is

attached to the tube of the other medical infusion line
connected to the connection port, the infusion circuit can be
opened and closed only by opening and closing the pinchcock.
This is convenient and can prevent an improper operation.
Furthermore, connection without a needle can be achieved, thus
improving safety.

In Fig. 13 showing a connection system 200 for an infusion
circuit according to an embodiment of the present invention, the
reference numeral 201 denotes a connection tool for an infusion
circuit, 202 one infusion line, 203 another infusion line, 204
43


CA 02512775 2005-07-07

and 205 infusion bags, and 206 a lock type syringe.

A feature of the connection system 200 of the present
embodiment is as follows. The aforementioned connection tool 201
for an infusion circuit is attached to the medical infusion line

202. By pressing and deforming a sealing valve for a medical
apparatus, mounted in each connection port of the connection
tool, by means of the tip end of the tube of the other medical
infusion line 202 or the tip end of the syringe 206, the valve
hole can be opened without inserting the tube of the other

medical infusion line 202 or the syringe into the valve hole. In
this manner, it is possible to connect the tube of the other
medical infusion line 203 or the syringe 206 to the medical
infusion line 202.

According to this connection system 200, since it employs
the aforementioned connection tool 201, high degree of freedom
in connecting the tube of the other medical infusion line 203 or
the syringe 206 to the medical infusion line 202 can be achieved.
Thus, a complicated infusion circuit can be formed easily.
Moreover, since the tube of the other medical infusion line 203

or the syringe 206 can be connected without using a needle, the
operation can be done with improved safety. Furthermore, the
valve hole of the sealing valve is opened by pressing and
deforming the sealing valve by means of the tip end of the tube
of the other medical infusion line 203 or the tip end of the
44


CA 02512775 2005-07-07

syringe 206, without inserting the tube of the other medical
infusion line 203 or the syringe 206 into the valve hole. Thus,
the valve hole can be designed easily, resulting in easier
fabrication of the sealing valve.

The sealing valve of the present invention is not limited
to the shapes exemplified in the above embodiments.

For example, a portion in which the valve hole is formed
may be formed in such a manner both upper and lower faces are
flat or they are arched and convex, although not shown. Moreover,

the upper face may be flat while the lower face is arched and
concave or convex. Alternatively, the lower face may be flat
while the upper face is arched and concave or convex.
Furthermore, the upper face may be arched and concave while the
lower face is flat or arched and convex. Alternatively, the

upper face may be arched and convex while the lower face is flat
or arched and concave.

Among the sealing valves mentioned above, in the sealing
valve in which the portion with the valve hole formed therein is
formed to have the upper face and/or the lower face that are/is

arched and concave, larger compression stress acts at or near
the valve hole. Thus, an excellent advantage that the valve hole
is pressed and hermetically sealed surely can be achieved.

Moreover, in a sealing valve 210 in a form of a cylinder
with a ceiling, for example, when a lower face 212b of a ceiling


CA 02512775 2005-07-07

212 with a valve hole 211 is formed therein is formed to be
arched and convex, as shown in Fig. 14, it is difficult for the
valve hole 211 to be opened against a fluid pressure inside a
mixed injection tube 213, thus improving pressure resistance of

the sealing valve 210. (Please note that the ceiling 212 formed
in the valve hole 211 has the upper face 212a that is arched and
concave in such a manner that the upper face 212a becomes
concave downward in the embodiment shown in Fig. 14.) In Fig. 14,
the reference numeral 214 denotes a cap member, 215 a sleeve
portion, and 216 a screwing piece.

The sealing valve and the connection port mentioned above
can be arranged at a site to which a syringe or connector is
connected, such as an opening portion of an infusion bag, other
than the mixed injection tube.

Although a screwing structure is exemplified as a structure
for connecting and locking a syringe or connector in the above
description, an insertion port to which a syringe or connector
is to be inserted may be tapered to have a gradually reduced
diameter in such a manner that the syringe or connector can be

connected and locked by taper fitting with that insertion port.
46

Representative Drawing
A single figure which represents the drawing illustrating the invention.
Administrative Status

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Administrative Status , Maintenance Fee  and Payment History  should be consulted.

Administrative Status

Title Date
Forecasted Issue Date 2011-03-22
(86) PCT Filing Date 2004-01-08
(87) PCT Publication Date 2004-07-29
(85) National Entry 2005-07-07
Examination Requested 2007-09-10
(45) Issued 2011-03-22
Deemed Expired 2018-01-08

Abandonment History

There is no abandonment history.

Payment History

Fee Type Anniversary Year Due Date Amount Paid Paid Date
Registration of a document - section 124 $100.00 2005-07-07
Application Fee $400.00 2005-07-07
Maintenance Fee - Application - New Act 2 2006-01-09 $100.00 2005-11-08
Maintenance Fee - Application - New Act 3 2007-01-08 $100.00 2006-11-21
Request for Examination $800.00 2007-09-10
Maintenance Fee - Application - New Act 4 2008-01-08 $100.00 2007-12-17
Maintenance Fee - Application - New Act 5 2009-01-08 $200.00 2008-11-27
Maintenance Fee - Application - New Act 6 2010-01-08 $200.00 2009-12-21
Maintenance Fee - Application - New Act 7 2011-01-10 $200.00 2010-11-22
Final Fee $300.00 2011-01-06
Maintenance Fee - Patent - New Act 8 2012-01-09 $200.00 2011-12-02
Maintenance Fee - Patent - New Act 9 2013-01-08 $200.00 2012-11-26
Maintenance Fee - Patent - New Act 10 2014-01-08 $250.00 2013-11-26
Maintenance Fee - Patent - New Act 11 2015-01-08 $250.00 2014-11-19
Maintenance Fee - Patent - New Act 12 2016-01-08 $250.00 2015-11-26
Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
FUKAI KOGYO KABUSHIKI KAISHA
Past Owners on Record
FUKAI, AKITOSHI
OKUI, YOSHIHITO
TAKEUCHI, TOSHIAKI
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column. To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Representative Drawing 2011-02-21 1 13
Cover Page 2011-02-21 2 52
Abstract 2005-07-07 2 81
Claims 2005-07-07 7 209
Drawings 2005-07-07 14 186
Description 2005-07-07 46 1,559
Representative Drawing 2005-07-07 1 13
Cover Page 2005-09-27 1 50
Description 2009-10-02 46 1,561
Claims 2009-10-02 6 152
Drawings 2009-10-02 14 194
Claims 2010-07-26 6 156
PCT 2005-07-07 4 146
Assignment 2005-07-07 5 143
Prosecution-Amendment 2009-10-02 15 421
Prosecution-Amendment 2007-09-10 1 32
Prosecution-Amendment 2009-04-06 3 105
Prosecution-Amendment 2010-02-25 2 74
Prosecution-Amendment 2010-07-26 9 271
Correspondence 2011-01-06 1 32